Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-19

Clinical Trial Update: Anti-bacterial Potential of Nano Calcium Hydroxide as an Intracanal Medication [Phase 2, Phase 3]

View source ↗

Summary

This document discusses an ongoing Phase 2/Phase 3 clinical trial testing nano calcium hydroxide as an antibacterial intracanal medication for endodontic and pu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nano calcium hydroxide (calcium hydroxide nanoparticles) (calcium hydroxide nanoparticles)

Snippet

Sponsor: British University In Egypt | Conditions: Endodontic Disease, Pulp Disease, Dental | Phase 2, Phase 3 | Status: RECRUITING